Corcept Therapeutics Inc
NASDAQ:CORT
| Market Cap (Intraday) | 7.36B |
| Current PE | 55.07 |
| Forward PE | 64.56 |
| 2yr Forward PE | 31.98 |
| 10-Day MA | $70.09 |
| 50-Day MA | $70.97 |
| 200-Day MA | $65.67 |
Corcept Therapeutics Inc Stock, NASDAQ:CORT
101 Redwood Shores Parkway, Redwood City, California 94065
United States of America
Phone: +1.650.327.3270
Number of Employees: 500
Description
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.